Elsevier

Annals of Oncology

Volume 29, Issue 11, November 2018, Page 2269
Annals of Oncology

Corrigendum
“Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC”

https://doi.org/10.1093/annonc/mdx807
Under a Creative Commons license
open access

Cited by (0)